Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Phase I/II Trial of Gabapentin Plus Ketamine for Prevention and Treatment of Acute and Chronic Pain in Locally Advanced Head and Neck Cancer Patients Undergoing Primary or Adjuvant Chemoradiation

To see complete record on, please visit this link

Id: NCT05156060

Organisation Name: Vanderbilt-Ingram Cancer Center

Overal Status: Recruiting

Start Date: January 24, 2022

Last Update: March 4, 2022

Lead Sponsor: Natalie Lockney

Brief Summary: This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergoing chemoradiation.

  • Head and Neck Cancer
  • Locally Advanced Head and Neck Carcinoma

Total execution time in seconds: 0.29983305931091